Search

Your search keyword '"Holmes FA"' showing total 11 results

Search Constraints

Start Over You searched for: Author "Holmes FA" Remove constraint Author: "Holmes FA" Topic antineoplastic agents Remove constraint Topic: antineoplastic agents
11 results on '"Holmes FA"'

Search Results

1. Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial.

2. PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.

Catalog

Books, media, physical & digital resources

3. Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL.

4. Cell line derived multi-gene predictor of pathologic response to neoadjuvant chemotherapy in breast cancer: a validation study on US Oncology 02-103 clinical trial.

5. Phase II trial of 10-EDAM in the treatment of metastatic breast cancer.

6. Phase II study of mitoxantrone by 14-day continuous infusion with granulocyte colony-stimulating factor (GCSF) support in patients with metastatic breast cancer and limited prior therapy.

7. A phase II study of CI-973 [SP-4-3(R)]-1,1-cyclobutane-dicarboxylato (2-)] (2-methyl-1,4-butanediamine-N, N') platinum in patients with refractory advanced breast cancer.

8. Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer.

9. Phase I trial of droloxifene in patients with metastatic breast cancer.

10. Phase II trial of fazarabine (ARA-AC, arabinosyl-5-azacytosine) in metastatic breast cancer.

11. Elliptinium acetate in metastatic breast cancer--a phase II study.